Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

Abstract Background Thrombotic microangiopathy (TMA) is a potentially organ and life-threatening condition affecting patients with multiple myeloma (MM). Cases of proteasome inhibitor-induced TMA and specifically carfilzomib-induced TMA have been rarely reported and standards for diagnostic workup a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lorenzo Catanese, Katharina Link, Harald Rupprecht
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-06-01
coleção:	BMC Nephrology
Assuntos:	Case report Thrombotic microangiopathy (TMA) Multiple myeloma (MM) Carfilzomib Eculizumab
Acesso em linha:	https://doi.org/10.1186/s12882-023-03228-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!